Schedule for Master Class Live In Person

• 6:45am - 7:15am

  Registration and Breakfast

• 7:15am - 7:25am

  Welcome and Opening Remarks

Session 1 - Malignant and Non-Malignant Hematology

• 7:25am - 8:10am

  Non-Hodgkin and Hodgkin Lymphoma: An Individualized Treatment Approach

  Ann S. LaCasce MD, MMSC

• 8:10am - 8:55am

  Myeloid Malignancies: Molecular Markets and Targeted Therapies

  Daniel J. DeAngelo, MD, PhD

• 8:55am - 9:20am

  Molecular Drivers of Myeloproliferative Neoplasms: Impact on Diagnosis, Assessment, and Management

  Ayalew Tefferi, MD

• 9:20am - 9:45am

  Multiple Myeloma: Current Evidence-Based Management

  Kenneth C. Anderson, MD

• 9:45am - 10:10am

  Chronic Lymphocytic Leukemia: Evaluating the Rapidly Changing Treatment Landscape

  Matthew S. Davids MD, MMSC

• 10:10am - 10:25am

  Refreshment Break

• 10:25am - 10:55am

  Current and Future Treatment Strategies for Cancer Associated Thrombosis

  Jean M. Connors MD

• 10:55am - 11:25am

  Reducing the Sickle Cell Disease Burden with Novel Treatment Targets

  Alexis A. Thompson MD, MPH

• 11:25am - 12:00pm

  Panel Discussion

  All Faculty

• 12:00pm - 12:45pm

  Lunch

Session 2 – Women’s Cancers and Supportive Care

Supportive Care

• 12:45pm - 1:10pm

  Sexual Health in Cancer Survivors

  Sharon L. Bober, PhD

• 1:10pm - 1:35pm

  Supportive and Palliative Care: Managing Symptoms and Toxicities to Improve Patient Outcomes

  Janet L. Abrahm, MD

• 1:35pm - 1:55pm

  Supportive Care Questions and Answers

• 1:55pm - 2:10pm

  Refreshment Break

Breast Cancers

• 2:10pm - 2:50pm

  HER2-Positive Breast Cancer and Triple-Negative Breast Cancer: An Evolving Treatment Landscape

  Nancy U. Lin MD

• 2:50pm - 3:15pm

  Advances in Hormone Receptor Positive Breast Cancer and Hereditary Breast Cancer Syndromes

  Harold J. Burstein MD, PhD

Gynecologic Cancers

• 3:30pm - 4:00pm

  Molecular Advances and Emerging Treatment Strategies In Ovarian Cancer

  Ursula A. Matulonis, MD

• 4:00pm - 4:25pm

  Molecular Advances and Emerging Treatment Strategies In Endometrial Cancer

  Joyce F. Liu, MD, MPH

• 4:25pm - 4:55pm

  Panel Discussion

  All Faculty

• 4:55pm

  Day One Adjournment

• 6:45am - 7:15am

  Registration and Breakfast

• 7:15am - 7:20am

  Welcome Back

Session 3 – Gastrointestinal Cancers and Sarcoma

Gastrointestinal Cancers

• 7:20am - 8:05am

  Colorectal Cancer: Molecular Markers and Evidence-Based Best Practices for Systemic Treatment

  Robert J. Mayer MD

• 8:05am - 8:25am

  Novel Treatments for Neuroendocrine Tumors: Using Patient and Tumor Characteristics to Guide Treatments

  Jennifer A. Chan, MD, MPH

• 8:25am - 9:10am

  Novel Approaches for the Management of Esophageal, Gastric, and Pancreatic Cancers

  Peter C. Enzinger, MD

• 9:10am - 9:30am

  Hepatobiliary Cancer: Predictive Biomarkers, Novel Agents, and Patient Monitoring

  Thomas A. Abrams, MD

• 9:30am - 9:45am

  Refreshment Break

• 9:45am - 10:25am

  Hereditary Gastrointestinal Cancers: From Family History to Management with Combination Therapy

  Matthew B. Yurgelun, MD

• 10:25am - 10:55am

  Panel Discussion

  All Faculty

Sarcoma

• 10:55am - 11:25am

  Best Practices and Expanding Treatment Options in Soft Tissue Sarcoma

  George D. Demetri, MD

• 11:25am - 11:35am

  Sarcoma Questions and Answers

• 11:35am - 12:20pm

  Lunch

Session 4 – Head, Neck and Lung Cancers and Melanoma

Head, Neck and Lung Cancers

• 12:20pm - 1:00pm

  Emerging Agents in the Multimodal Management of Head, Neck, and Thyroid Cancers

  Robert I. Haddad, MD

• 1:00pm - 1:50pm

  NSCLC and SCLC: Molecular Testing and Emerging Treatment Options

  Bruce E. Johnson MD

Melanoma Cancer

• 1:50pm - 2:25pm

  Evidence-Based Treatment Approaches for Adjuvant, Advanced, and Metastatic Melanoma

  F. Stephen Hodi, MD

• 2:25pm - 2:55pm

  Panel Discussion

  All Faculty

• 2:55pm - 3:10pm

  Refreshment Break

Session 5 – Genitourinary Cancers

• 3:10pm - 4:00pm

  Prostate Cancer: An Evolving Treatment Landscape

  Mary Ellen Taplin, MD

• 4:00pm - 4:35pm

  Treatment Selection in Renal Cell and Urothelial Carcinoma: Integrating Novel Agents into Daily Practice

  Robert Dreicer, MD

• 4:35pm - 5:05pm

  Panel Discussion

  All Faculty

• 5:05pm - 5:10pm

  Closing Remarks

• 5:10pm

  Course Adjournment